SCM
VIRX

Silverarc Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Silverarc Capital Management’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,570
Closed -$264K – 114
2021
Q1 		$264K Buy
+28,570
New +$264K 0.14% 80